Access to HAART and utilization of inpatient medical hospital services among HIV-infected patients with co-occurring serious mental illness and injection drug use
about
Quality of medical care for persons with serious mental illness: A comprehensive reviewA socio-ecological perspective of access to and acceptability of HIV/AIDS treatment and care services: a qualitative case study research.Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings.Mortality after diagnosis of psychiatric disorders and co-occurring substance use disorders among HIV-infected patients.Is serious mental illness associated with earlier death among persons with HIV? Ten year follow up in Maryland Medicaid Recipients.HIV patients with psychiatric disorders are less likely to discontinue HAART.Predictors of highly active antiretroviral therapy utilization for behaviorally HIV-1-infected youth: impact of adult versus pediatric clinical care siteHalf of 30-Day Hospital Readmissions Among HIV-Infected Patients Are Potentially PreventablePsychiatric correlates of HAART utilization and viral load among HIV-positive impoverished persons.High-dose valacyclovir decreases plasma HIV-1 RNA more than standard-dose acyclovir in persons coinfected with HIV-1 and HSV-2: a randomized crossover trial.HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug useTreatment considerations for HIV-infected individuals with severe mental illness.The impact of an HIV/AIDS adult integrated health program on leaving hospital against medical advice among HIV-positive people who use illicit drugs.Impact of depression and recreational drug use on emergency department encounters and hospital admissions among people living with HIV in Ontario: A secondary analysis using the OHTN cohort study.
P2860
Q27026165-DDB46CC5-6C84-4014-970C-535B297AA799Q27310382-18AFE3BC-F512-4E2A-B3D9-BCDBE1B67C78Q33729687-5B93AD4F-855B-447D-89A2-53508C855361Q34365075-7AADFDA3-1F1F-4A6D-A209-D3775ED75CFCQ34400040-A8E4A627-9D46-4513-8A4F-DFF1066E8751Q35545476-EA2FF12A-C3EE-4A78-89AF-487E679C9CFAQ35917251-641AAF94-E11C-458F-BB93-3B8C78AAAD3AQ36041402-B7A41AE5-3675-45B0-82E3-82DD2F14A944Q36696253-20FD5D85-BB09-46DF-AFBF-90A49F83AAE1Q37081751-6A1E7773-F4E7-49CA-B3C4-CD12EF569EAAQ37307322-4E23F9B4-E8F1-438A-BC72-D8D0C3158BFEQ37378642-C438DFE8-8B50-4E48-B62D-58DFDF9839D2Q50610500-2D471FF5-E8C9-43F0-85BB-9800E6184D73Q52598809-20AB4C4F-5C0F-49E8-89EA-204D012113D8
P2860
Access to HAART and utilization of inpatient medical hospital services among HIV-infected patients with co-occurring serious mental illness and injection drug use
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Access to HAART and utilizatio ...... illness and injection drug use
@en
Access to HAART and utilizatio ...... llness and injection drug use.
@nl
type
label
Access to HAART and utilizatio ...... illness and injection drug use
@en
Access to HAART and utilizatio ...... llness and injection drug use.
@nl
prefLabel
Access to HAART and utilizatio ...... illness and injection drug use
@en
Access to HAART and utilizatio ...... llness and injection drug use.
@nl
P2093
P2860
P1476
Access to HAART and utilizatio ...... illness and injection drug use
@en
P2093
Geetanjali Chander
James Hellinger
John A Fleishman
Kelly A Gebo
Paul Gaist
Seth Himelhoch
P2860
P304
P356
10.1016/J.GENHOSPPSYCH.2007.03.008
P577
2007-11-01T00:00:00Z